Parkwalk Advisors's Biotechnology Portfolio

Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes.

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

Scripta Therapeutics operates as a bio-tech company.

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Zentraxa has specialise in the design, production and testing of complex novel peptides.

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.

Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

PetMedix is a pet therapeutics startup.

Carbometrics is a specialist chemistry company to help people with diabetes to live more normal and longer lives.

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Istesso is a drug discovery and development company working in the field of immunometabolism.